Epilepsy drug brings hope for multiple sclerosis patients
Advertisement
Washington: A commonly-used epilepsy drug has brought hope for multiple sclerosis sufferers as it may help prevent nerve damage.
The University College London study found that the drug phenytoin slowed the progress of optic neuritis, a symptom leading to blurred vision, and scientists believe it could have a similar protective effect throughout the brain.
Currently there are no neuroprotective drugs available for MS sufferers, whose nerve fibres are attacked by their own immune system.
The University College London study found that the drug phenytoin slowed the progress of optic neuritis, a symptom leading to blurred vision, and scientists believe it could have a similar protective effect throughout the brain.
Currently there are no neuroprotective drugs available for MS sufferers, whose nerve fibres are attacked by their own immune system.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.